| Product Code: ETC10088058 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam mRNA Flu Vaccine Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam mRNA Flu Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam mRNA Flu Vaccine Market - Industry Life Cycle |
3.4 Vietnam mRNA Flu Vaccine Market - Porter's Five Forces |
3.5 Vietnam mRNA Flu Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Vietnam mRNA Flu Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Vietnam mRNA Flu Vaccine Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Vietnam mRNA Flu Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of mRNA flu vaccines |
4.2.2 Growing healthcare infrastructure and investment in Vietnam |
4.2.3 Rising prevalence of flu cases in the region |
4.3 Market Restraints |
4.3.1 High cost of mRNA flu vaccines compared to traditional flu vaccines |
4.3.2 Limited access to advanced healthcare facilities in rural areas of Vietnam |
4.3.3 Regulatory challenges and approval processes for mRNA vaccines in the country |
5 Vietnam mRNA Flu Vaccine Market Trends |
6 Vietnam mRNA Flu Vaccine Market, By Types |
6.1 Vietnam mRNA Flu Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By Non-replicating mRNA, 2021- 2031F |
6.1.4 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By In Vivo Self-Replicating mRNA, 2021- 2031F |
6.1.5 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By In Vitro Dendritic Cell Non-Replicating mRNA Vaccine, 2021- 2031F |
6.2 Vietnam mRNA Flu Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1010, 2021- 2031F |
6.2.3 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1020, 2021- 2031F |
6.2.4 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By mRNA-1030, 2021- 2031F |
6.3 Vietnam mRNA Flu Vaccine Market, By End use |
6.3.1 Overview and Analysis |
6.3.2 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By Clinic, 2021- 2031F |
6.3.3 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Vietnam mRNA Flu Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam mRNA Flu Vaccine Market Import-Export Trade Statistics |
7.1 Vietnam mRNA Flu Vaccine Market Export to Major Countries |
7.2 Vietnam mRNA Flu Vaccine Market Imports from Major Countries |
8 Vietnam mRNA Flu Vaccine Market Key Performance Indicators |
8.1 Percentage of population vaccinated with mRNA flu vaccines |
8.2 Number of healthcare facilities offering mRNA flu vaccines |
8.3 Research and development investment in mRNA flu vaccine technology |
8.4 Rate of flu cases in Vietnam |
8.5 Government initiatives to promote vaccination awareness and uptake |
9 Vietnam mRNA Flu Vaccine Market - Opportunity Assessment |
9.1 Vietnam mRNA Flu Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Vietnam mRNA Flu Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Vietnam mRNA Flu Vaccine Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Vietnam mRNA Flu Vaccine Market - Competitive Landscape |
10.1 Vietnam mRNA Flu Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Vietnam mRNA Flu Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here